Gene: OSBPL1A
Official Full Name: oxysterol binding protein like 1Aprovided by HGNC
Gene Summary: This gene encodes a member of the oxysterol-binding protein (OSBP) family, a group of intracellular lipid receptors. Most members contain an N-terminal pleckstrin homology domain and a highly conserved C-terminal OSBP-like sterol-binding domain, although some members contain only the sterol-binding domain. Transcript variants derived from alternative promoter usage and/or alternative splicing exist; they encode different isoforms. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30715 | OSBPL1A Knockout cell line (HeLa) | Human | OSBPL1A | 1:3~1:6 | Negative | Online Inquiry |
KO30716 | OSBPL1A Knockout cell line (HCT 116) | Human | OSBPL1A | 1:2~1:4 | Negative | Online Inquiry |
KO30717 | OSBPL1A Knockout cell line (HEK293) | Human | OSBPL1A | 1:3~1:6 | Negative | Online Inquiry |
KO30718 | OSBPL1A Knockout cell line (A549) | Human | OSBPL1A | 1:3~1:4 | Negative | Online Inquiry |
OSBPL1A Gene Knockout Cell Lines represent a cutting-edge tool for the study of lipid metabolism and cellular signaling pathways involved in various diseases. These cell lines are specifically engineered to exhibit a complete disruption of the OSBPL1A gene, which encodes a protein known for its role in phospholipid transport and signaling. By utilizing gene knockout technology, researchers can investigate the functional consequences of the absence of OSBPL1A, providing insights into lipid biogenesis, intracellular signaling, and potential disease mechanisms.
The key function of these knockout cell lines lies in their ability to model the physiological and pathological conditions associated with OSBPL1A deficiency. This deficiency has been implicated in multiple biological processes, including cholesterol metabolism and regulation of endosomal trafficking. The mechanisms through which OSBPL1A operates offer critical insights for designing therapeutic interventions aimed at metabolic disorders and cancer research, where lipid dysregulation plays a pivotal role.
The scientific importance of OSBPL1A Gene Knockout Cell Lines is underscored by their relevance in translational research. These cell lines can be employed in high-throughput screening for drug discovery, enabling the identification of compounds that might restore normal function or mitigate the effects of OSBPL1A loss. In clinical settings, they serve as valuable models for studying various diseases, including atherosclerosis and certain cancers, facilitating the development of targeted therapies.
Compared to alternative cell lines, the unique advantage of OSBPL1A Knockout Cells lies in their specificity and accuracy in modeling OSBPL1A-related processes. Conventional methods, such as pharmacological inhibition, often yield inconsistent results due to off-target effects. In contrast, these knockout cells provide a clean, consistent system for investigating the direct effects of OSBPL1A absence, along with its downstream signaling pathways.
For researchers and clinicians focused on understanding the nuances of lipid metabolism and its implications for health and disease, OSBPL1A Gene Knockout Cell Lines are an invaluable asset. They streamline experimental workflows while producing reliable data that can be translated into novel therapeutic solutions.
At our company, we pride ourselves on leading the field in the development of biological products, ensuring that our offerings are underpinned by robust scientific research and are tailored to meet the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.